Abstract
Micro- or macro-circulatory insufficiency has a negative impact in patients with Alzheimer’s disease (AD). This study used arterial spin-labeled magnetic resonance imaging (ASL-MRI) and ethylcysteinate dimer single-photon emission computed tomography (ECD-SPECT) in 50 patients with AD and 30 age-matched controls to investigate how hypoperfusion patterns were associated with gray matter atrophy and clinical data. All participants completed 3DT1-MRI, ECD-SPECT and ASL-MRI examinations. Medial temporal cortex (MTC) volumes were correlated with regional signals showing significantly lower relative cerebral blood flow (rCBF) in ASL-MRI or perfusion index (PI) in ECD-SPECT. Neurobehavioral scores served as the outcome measures. Regions with lower PI showed spatial similarities with atrophy in the medial, anterior and superior temporal lobes, posterior cingulate cortex and angular gyrus, while regions showing lower rCBF were localized to the distal branches of posterior cerebral artery territories (posterior parietal and inferior temporal lobe) and watershed areas (angular gyrus, precuneus, posterior cingulate gyrus and middle frontal cortex). rCBF values in watershed areas correlated with MTC volumes and language composite scores. Precuneus and angular gyrus hypoperfusion were associated with the corresponding cortical atrophy. Macro- or micro-vasculature perfusion integrities and cortical atrophy determined the overall perfusion imaging topography and contributed differently to the clinical outcomes.
Introduction
In late-onset Alzheimer’s disease (AD), atrophy of the medial temporal cortex (MTC) and posterior parietal cortex are early structural changes1, while amyloid toxicity2 is generally thought to underlie the degenerative mechanism. The subsequent appearance of synapse loss, amyloid plaques and neurofibrillary tangle formation2, may then lead to the onset of cognitive impairment. The presence of vascular risk factors3 and advanced aging process may then act in combination with the pathological processes to trigger cerebral macro- or micro-circulatory disturbances4.
Arterial spin labeling-magnetic resonance imaging (ASL-MRI)5 and ethyl cysteinate dimer single-photon emission computed tomography (ECD-SPECT)6 both measure cerebral perfusion. In ASL-MRI, magnetically labeled arterial blood serves as a diffusible endogenous tracer to quantify perfusion, thereby avoiding the need for injections and exposure to ionizing radiation5. ASL-MRI findings have been shown to be closely correlated with those of 15O-water positron emission tomography7, however study also showed that ASL-MRI systematically underestimated CBF especially in voxels supplied by two arteries8. Furthermore, morphological information can be obtained with good spatial resolution by means of three-dimensional (3D) T1 images. The most consistent finding in the literature of ASL-MRI applied to AD is a decreased CBF in the precuneus, angular gyrus and posterior cingulate cortex (PCC)9. A recent report suggested that the default mode network may be comprised of multiple, spatially dissociated but interactive components, of which two subsystems are particularly relevant: the “medial temporal lobe subsystem”, and the “dorsal medial prefrontal cortex subsystem” (or the midline core subsystem)10. Both PCC and precuneus areas have been reported to represent important cortical hubs of the midline core subsystem11.
The limitations of ECD-SPECT in quantifying perfusion include low spatial resolution and the lack of absolute values12, however signal retention has been shown to be highly parallel to regional CBF13. In the diagnostic criteria of AD14 ECD-SPECT is considered to be a reliable clinical biomarker reflecting neuronal injury. However, the role of ASL-MRI has yet to be clarified, and comparisons with ECD-SPECT may help to elucidate its diagnostic repertoire. Reported levels of agreement among cortical areas between MRI and SPECT perfusion are highly variable15,16.
The top-down modulation theory between posterior brain network hypoperfusion and MTC cortical atrophy is still under debate. One theory supports upstream hippocampal atrophy and downstream posterior parietal cortical hypoperfusion17, whereas another postulates that vascular damage and reduced perfusion in the parietal association cortex, PCC and precuneus lead to the initiation and aggravation of AD pathology in the MTC18. Although the metabolic changes of default mode network and medial temporal atrophy are well known, multi-parametric modalities using ECD-SPECT and ASL-MRI with structural comparisons to delineate the top-down modulation theory in patients with AD are still lacking.
Based on the hypothetical models of dynamic biomarkers in AD17, the study explored the topography similarities and differences among 3 imaging modalities, ASL-MRI, 3DT1-MRI and SPECT. By regression models, we proposed possible mechanisms for the mismatch of cerebral hypoperfusion and gray matter (GM) atrophy. The impact of reduced CBF and cognitive scores were used to validate the clinical significance of vascular risk factors.
Materials and Methods
This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Chang Gung Memorial Hospital. The study participants and their caregivers agreed on the participation of the study with written informed consent. The study participants were treated at the Cognition and Aging Center, Department of General Neurology, Kaohsiung Chang Gung Memorial Hospital. A total of 50 patients with AD and 30 healthy age-matched controls were included after the consensus of a panel composed of neurologists, neuropsychologists, neuroradiologists and experts in nuclear medicine19. AD was diagnosed according to the International Working Group criteria20 with a clinical diagnosis of typical AD. All of the patients had a clinical dementia rating (CDR) score of 0.5 or 1. The age-matched controls were selected from a normal cohort database, and all had normal cognition and basic biochemical profiles21. All of the patients with AD in this study received acetylcholine esterase inhibitors as standard treatment. The exclusion criteria were a past history of clinical stroke, a modified Hachinski ischemic score >422 and moderate to severe stenosis (>50% stenosis) of major extra- or intra-cranial arteries by Doppler23. Patients with vascular stenosis or stroke were excluded because their asymmetric cerebral perfusion profile may have outweighed the degenerative process and confounded the results.
Clinical and cerebral vascular risk factors
After enrolment, the demographic data of each patient were recorded. Cerebral vascular risk factors included age, high sensitivity C-reactive protein (hsCRP), total cholesterol, triglycerides, high-density lipoprotein (HDL), low-density lipoprotein, creatinine, and the presence of diabetes mellitus24 and hypertension25. The genotype of apolipoprotein E (APOE) was determined by polymerase chain reaction-restriction fragment length polymorphism assay and restriction enzyme HhaI19. APOE4 carriers were defined as those with one or two APOE4 alleles.
Neurobehavioral assessments
A trained neuro-psychologist administered the neurobehavioral tests. The Mini-Mental State Examination (MMSE)26 and Cognitive Abilities Screening Instrument (CASI)27 total scores were used as a global assessment of cognitive function. In the CASI, the subdomain scores of verbal fluency and language were summarized as the language composite score to reflect the general language skill.
Image acquisition
3DT1 and ASL-MRI
MRI was performed on a 1.5T scanner (Discovery MR450, GE Healthcare, Milwaukee, WI) with an 8-channel head coil. High-resolution T1-weighted images of the whole brain anatomy were acquired using 3D spoiled gradient-recalled acquisitions in steady state sequences with the following parameters: repetition time/echo time/flip angle = 8.616 ms/4.2 ms/12°. One hundred and sixty sagittal slices covering the whole brain were acquired in 9 minutes and 14 seconds, with an isotropic spatial resolution of 1 mm3.
Resting CBF measurements were acquired using a pseudocontinuous ASL technique28 with a background-suppressed 3D fast spin echo sequence. The imaging parameters were as follows: TR/TE/label time/post-label delay = 4652/10.5/1500 /1525/ms, voxel size = 3.64 × 3.64 × 4 mm3, slice thickness = 4 mm, number of excitations = 3, number of slices = 38 and a scan time of 4 minutes to cover the whole brain. The study protocol followed that by Sigurdsson et al.29 that showed reliability for geriatric population at 1.5 Tesla MRI. The exclusion of patients with vascular stenosis was to reduce the possibility of prolonged arterial transit time. We didn’t use the vascular crushing gradients because it would reduce the signal-to-noise ratio. Besides, in normal situation, the labeled bolus will be delivered to target tissues and little labeled blood will be in large arteries at the time of imaging. In contrast, if extremely prolonged arterial transit time, bright vascular signals could be removed using vascular crushing gradients, but the quantitative CBF values in areas distal to the large vessel are error30.
The ASL perfusion imaging was constructed by the following images: one image taken shortly after the inflowing arterial spins were inverted (i.e. label image), another taken without inverting the arterial spins (i.e. control image) and the third one was the reference image used to quantify the CBF. Subtracting the label image from the control image produced an ASL perfusion-weighted image, which was then converted to a quantitative image that reflected CBF. For each subject, the CBF map was calculated using a scanner console with FuncTool 3DASL (DiscoveryMR450, GE Healthcare, Milwaukee, WI) within 1 minute. The signal is reported as mL/100 g/minute. The ASL-derived perfusion maps for each participant were carefully checked by an experienced neuroradiologist (C.C. Lui) to ensure the imaging quality was in accordance with the recommendation of the consensus30. These parameters included the scanner related artifacts, motion artifact or whether there was insufficient labeling due to prolonged arterial transit time. The images that were not qualified were excluded from the study and the represented images are shown in Fig. 1.
ECD-SPECT images
All subjects were injected intravenously with a single bolus dose of 110 MBq (30 mCi) 99mTc-ECD. Brain SPECT/CT (Symbia T; Siemens, Erlangen, Germany) images were obtained 30 minutes later. The SPECT/CT scanner was equipped with low-energy, high-resolution collimators and a dual-slice spiral CT. The acquisition parameters for SPECT were a 128 × 128 matrix with 60 frames (40 s/frame), and the scan parameters for CT were 130 kV, 17 mA, 5-mm slices, and image reconstruction with a medium-smooth kernel. The SPECT images were attenuation-corrected based on the CT images and scatter-corrected with the Flash 3D algorithm (ordered subsets expectation and 3D maximization with resolution correction) with eight subsets and eight iterations.
Study scheme
Neuroimaging comparisons were processed using Spatial Parametric Mapping Version 8 software (The Wellcome Department of Imaging Neuroscience, London, UK) and customized MATLAB scripts (The Mathworks Inc., Natick, MA) with study-specific templates. In order to detect AD-related atrophy and hypoperfusion patterns, voxel-wise statistics were performed by comparing differences in 3DT1, ASL-MRI, and SPECT images between the patients and controls. The results were thresholded at p < 0.005, with false discovery rate correction for multiple comparisons and a cluster threshold of 200 voxels. Detailed pre-processing steps for each image type are listed below.
Structural image pre-processing
The 3DT1 images were processed using voxel-based morphometry version 831. All 3DT1-weighted images were spatially normalized into the standardized Montreal Neurological Institute (MNI) space using a 12-parameter affine transformation and non-linear normalization, followed by re-slicing onto a voxel size of 1 × 1 × 1 mm to minimize partial volume effects. The images were segmented into GM and white matter (WM) compartments with intensity inhomogeneity correction, and modulated with Jacobian determinants to compensate for volume changes in non-linear spatial normalization. The segmented images were then smoothed with a 8 × 8 × 8-mm full-width at half-maximum isotropic Gaussian kernel. The normalized and smoothed GM probability maps were entered into a two-sample t test with age and years of education as covariates to detect changes in GM volume in the patients with AD.
ASL-MRI image pre-processing
Because of low resolution of the CBF images, we corrected the partial volume effect to improve the accuracy of CBF quantification. High-resolution MR image was segmented into GM, WM and cerebrospinal fluid (CSF) probability maps. GM and WM probability maps were then smoothed with a 1.88 × 1.88 × 4 mm3 kernel to mimic the PVE of the ASL images. The smoothed GM probability maps were then subsampled to the spatial resolution of the CBF images and thresholded at >0.3. Intensities of CBF images were corrected according to the following equation: Icorrected = Iuncorrected/(PGM + 0.4 * PWM)32, where the 0.4 factor is the perfusion ratio between WM and GM, and PGM and PWM are the probabilities of GM and WM, respectively. The PVE-corrected CBF images were spatially normalized to MNI space, re-sliced onto a voxel size of 1 × 1 × 1 mm3 and smoothed using a Gaussian filter with full-width at half-maximum of 8 mm. To eliminate outliers in the perfusion image confounded by large blood vessels or image processing computations, the threshold was set at a low value threshold of zero and a high-value threshold of 2 standard deviations above the mean perfusion for each subject33. The relative CBF (rCBF) maps were calculated by dividing each image by its whole brain CBF, and the rCBF in each regions of interest was used for statistical comparisons. The rationale not to use the absolute CBF for regional comparisons was based on the reports by Aslan et al. and Chen et al.34,35 that the use of rCBF may greatly reduce the variations of inter-subject physiologic noise. A two-sample t test with age and years of education as covariates was used to detect regional rCBF changes in the patients with AD.
ECD-SPECT image pre-processing
SPECT perfusion maps were corrected for PVE as described in previous study36. Briefly, high-resolution MR image was segmented into GM and WM probability maps and coregistered to the corresponding SPECT images and re-sliced to the same voxel size. These re-sliced GM and WM images were then convoluted with a 7 mm FWHM isotropic Gaussian kernel. WM-SPECT image was obtained from the multiplication of the WM maps by the mean SPECT count for areas more than 95% in WM concentration. A GM-SPECT image was obtained by subtracting the WM-SPECT image from the SPECT image. Finally, the GM-SPECT image was divided by the GM-MR image, yielding a PVE-corrected SPECT image. The PVE-corrected SPECT images were spatially normalized to the MNI template, re-sliced onto a voxel size of 1 × 1 × 1 mm3 and smoothed using a Gaussian filter with full-width at half-maximum of 8 mm. For count normalization, we used the cerebellum as the reference37. SPECT PI maps were obtained by dividing the image by the mean uptake in the cerebellum (counts/pixel). A two-sample t test with age and years of education as covariates was used to detect regional PI changes in the patients with AD.
Regions of interest analysis
To validate the results by voxel-based analysis, several regions of interest highly characterized in the patients with AD were defined in accordance with the automated anatomic labeling template38 and arterial transit time based flow territories developed by Mutsaerts et al.39. They included the frontal (but excluding the primary motor cortex), lateral temporal, MTC, parietal, occipital, middle frontal cortex, angular, PCC, precuneus, precentral motor cortex and cerebral cortex in distal territory of posterior cerebral artery (PCA). The MTC referred to the hippocampus, para-hippocampus and amygdala38. The lateral temporal region of interest referred to the superior, middle and inferior temporal areas, and the superior and middle temporal pole areas.
Statistical analysis
All data were expressed as mean ± standard deviation. We used the Student’s t test for continuous variables and the chi-square test for categorical variables for comparisons between the patients and controls. In order to understand the effect of MTC atrophy on remote hypoperfusion, a linear regression model with adjustments for possible confounding covariates was used to evaluate the relationship between MTC volume and regional rCBF. Furthermore, we evaluated the relationships between regional PI and their corresponding GM volume by simple Pearson’s correlation, followed by multivariate linear regression analysis to test the independent effect of PI. Because MTC atrophy is a structural hallmark in AD and strongly associated with disease severity, we use MTC volume as one of the confounders in the multivariate linear regression analysis. The rCBF and PI images were entered into the linear regression model separately, which was adjusted for possible covariates, to evaluate associations with CASI total, short term memory, and language composite subdomain scores. Regression results were statistically thresholded at p < 0.05, with false discovery rate correction for multiple comparisons and a cluster threshold of 200 voxels. Pearson correlation analysis was used to test the relationships among cerebrovascular risk biomarkers and regional rCBF or PI, followed by multivariate linear regression analysis to test the independent associations. All statistical analyses were conducted using the Statistical Package for Social Sciences software package (SPSS version 22 for Windows®, SPSS Inc., Chicago, IL). Statistical significance was set at p < 0.01.
Ethics approval and consent to participate
This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Chang Gung Memorial Hospital (IRB 103-7745A3 and IRB 102-1298A3). The study participants and their caregivers agreed on the participation of the study with written informed consent.
Availability of data and material
The datasets generated during and/or analyzed during the current study are not publicly available due to the intelligence rights owned by the hospital and the authors but are available from the corresponding author on reasonable request.
Results
Characteristics of the subjects
Table 1 shows the data of the patients and controls. The patients had a higher prevalence of APOE4, fewer years of education, lower scores in the cognitive tests, and lower regional and global CBF values. Patients with AD showed significant lower absolute values of CBF in all predefined regions.
Table 1.
AD (n = 50) | Control (n = 30) | |
---|---|---|
Age (years) | 73.32(8.40) | 71.03(8.05) |
Education (years) | 5.3(4.51)* | 8.5(5.22) |
Gender (female, %) | 33(66%) | 18(60%) |
Diabetes Mellitus, cases (%) | 9(18%) | 6 (20%) |
Hypertension, cases (%) | 29(58%) | 17(56.7%) |
APOE4 carrier, cases (%) | 27(54%)* | 6(20%) |
High sensitivity C- reactive protein (mg/L) | 2.94(3.53) | 1.72(1.61) |
Creatinine (mg%) | 0.90(0.26) | 0.91(0.25) |
Total cholesterol (mg/dl) | 195(37.8) | 180(29.0) |
Triglyceride (mg/dl) | 116(59.4) | 109(47.2) |
High-density lipoprotein (mg/dl) | 57.3(13.3) | 55.7(16.7) |
Low-density lipoprotein (mg/dl) | 112(30.2) | 104(29.3) |
Mini-Mental State Examination | 16.78(5.13)* | 27.07(1.91) |
CASI total scores | 56.46(17.61)* | 85.81(6.00) |
Mental manipulation | 4.4(3.16)* | 8.4(1.59) |
Attention | 5.8(1.41)* | 6.9(0.92) |
Orientation | 10.6(4.56)* | 17.1(2.26) |
Long term memory | 7.4(2.75)* | 9.6(0.81) |
Short term memory | 3.0(2.08)* | 8.9(1.51) |
Abstract thinking | 6.8(2.40)* | 9.1(1.63) |
Drawing | 6.3(3.42)* | 9.3(1.06) |
Language Composite scores | 11.5(4.73)* | 16.5(2.43) |
Cerebral blood flow(ml/100 g/min) | ||
Global | 40.4(9.76)* | 47.1(7.13) |
Frontal cortex | 44.6(10.4)* | 50.6(7.01) |
Lateral temporal regions of interest | 42.5(7.54)* | 49.0(6.97) |
Medial temporal cortex | 40.0(9.23)* | 43.8(5.29) |
Occipital cortex | 34.0(10.1)* | 43.2(9.23) |
Parietal cortex | 37.9(10.7)* | 46.2(8.61) |
Data are presented as mean (standard deviation) or the number (frequency, %); *p < 0.01.
Abbreviations: CASI, Cognitive Abilities Screening Instrument; APOE4, Apolipoprotein E4.
Medial temporal cortex = hippocampus, para-hippocampus and amygdala.
Lateral temporal regions of interest = superior, middle and inferior temporal areas, and the superior and middle temporal pole areas.
Comparisons of two perfusion imaging modalities in patients and controls
The results of voxel-wise statistical analysis between the patients and controls are shown in Fig. 2. Regions with decreased PI were found primarily in the angular gyrus, PCC, anterior cingulate gyrus, anterior and superior temporal lobe. Meanwhile, decreases of PI in the MTC were also found (Fig. 2B and E). For rCBF analysis (Fig. 2C and F), lower rCBF were more extended and found in the following areas (vessel territories)39: inferior temporal lobe (distal PCA territory); posterior parietal cortex and angular gyrus (middle cerebral artery [MCA]-PCA border zone areas); precuneus and posterior cingulate gyrus (MCA-PCA-anterior cerebral artery [ACA] border zone areas); and middle prefrontal cortex (ACA-MCA border zone areas). The coordinates of these regions are shown in Table 2.
Table 2.
Anatomic label | x, y, z (mm) coordinates | Z score | Voxels | ||
---|---|---|---|---|---|
Gray matter volume | |||||
Right hippocampus | 22 | −33 | −3 | 6.50 | 6966 |
Left hippocampus | −22 | −18 | −13 | 7.05 | 18241 |
Right middle temporal | 51 | −9 | −18 | 7.06 | 4996 |
Right precuneus | 6 | −51 | 36 | 5.52 | 2195 |
Right middle occipital | 28 | −73 | 28 | 4.81 | 511 |
Relative cerebral blood flow (rCBF) | |||||
Right angular | 46 | −69 | 42 | 7.02 | 11059 |
Right superior frontal | 26 | 42 | 37 | 5.90 | 1939 |
Left superior frontal | −22 | 29 | 46 | 5.70 | 3246 |
Right middle frontal | 27 | 14 | 43 | 5.53 | 4453 |
Left middle frontal | −34 | 13 | 57 | 5.41 | 800 |
Perfusion Index (PI) | |||||
Left middle temporal pole | −30 | 13 | −35 | 6.14 | 4248 |
Right superior temporal pole | 52 | 5 | −8 | 5.77 | 7584 |
Right caudate | 13 | 22 | 8 | 4.84 | 1598 |
Left caudate | −11 | 7 | 11 | 6.10 | 2767 |
Left posterior cingulate | −4 | −31 | 29 | 4.98 | 1224 |
Right angular | 49 | −61 | 51 | 4.95 | 1199 |
Left angular | −50 | −61 | 48 | 4.45 | 526 |
Overlapping regions* | |||||
Left posterior cingulum | −6 | −43 | 24 | 6.09 | 3522 |
Left angular | −50 | −65 | 41 | 4.71 | 1318 |
Right angular | 42 | −74 | 43 | 4.72 | 501 |
*Indicate overlapping areas in volume, rCBF and PI.
The rCBF or PI signals from the pre-defined regions of interests were further extracted and compared between the patients and controls (Fig. 3). Combination with Figs 2 and 3, regions concurrently showing lower rCBF and PI in the patients were localized in the angular gyrus, PCC and precuneus gyrus, while the areas showing dissociations were seen in the superior temporal lobe and MTC (lower PI without lower rCBF) and distal PCA territory, inferior temporal lobe and middle frontal cortex (lower rCBF without lower PI). The perfusion in motor cortex did not show difference between AD and controls regardless the results of rCBF or PI.
Comparisons of functional (perfusion) and structural images (volumes) in patients and controls
Regions of atrophy were primarily localized in the medial and lateral temporal structures (Fig. 2A), PCC and angular gyrus (Fig. 2D). The coordinates of these regions are shown in Table 2. The spatial similarities between lower PI and atrophy were higher than lower rCBF and atrophy. The overlapping areas of lower PI and atrophy are located in medial temporal lobe, PCC and angular gyrus which were shown in Fig. 2G, and the regions showing lower PI, lower rCBF and atrophy included the PCC and angular gyrus (Fig. 2H). Lower rCBF without atrophy was mainly located in inferior temporal lobe, part of parietal association cortex and middle frontal cortex. Atrophy without lower rCBF was mainly located in medial temporal lobe.
The effect of MTC atrophy on remote rCBF
The rCBF signals that corresponded to the MTC volumes included PCC, left angular gyrus, bilateral caudate and left middle frontal cortex (Fig. 4A). For regions that showed overlap between GM atrophy, lower PI and rCBF (Fig. 2H), the overall rCBF values were extracted and combined. The combined rCBF was significantly correlated with MTC volume (Fig. 4B, r2 = 0.243, p < 0.01).
The relationship between regional perfusion and corresponding cortical volumes
The simple correlation showed regional PI were significant correlated with their corresponding cortical volumes (Table 3). After adjusted for age and MTC volumes, angular gyrus and precuneus volumes were still significant related to their own PI (for angular p = 0.008, for precuneus p = 0.006) (Table 3). The association in frontal lobe, occipital lobe, parietal lobe, middle frontal gyrus and PCC does not reach significance after adjusted for age and MTC volumes (p > 0.01).
Table 3.
Simple correlation+ | Adjusted correlation# | |
---|---|---|
Frontal | 0.456(0.000)* | 0.126(0.077) |
Lateral temporal | 0.553(0.000)* | 0.077(0.250) |
Occipital | 0.259(0.020) | 0.055(0.464) |
Parietal | 0.375(0.001)* | 0.161(0.061) |
Middle frontal | 0.421(0.000)* | 0.108(0.144) |
Angular | 0.493(0.000)* | 0.244(0.008)* |
Posterior Cingulate Cortex | 0.500(0.000)* | 0.176(0.114) |
Precuneus | 0.414(0.000)* | 0.244(0.006)* |
+Simple correlation, the correlation between regional PI and corresponding cortical volume (ex. Frontal represented the association between frontal PI and frontal volume).
#Multivariate linear regression analysis, corresponding cortical volume were dependents and regional PI were independents and adjusted for age and medial temporal cortex volume.
Abbreviations: PI, perfusion index from SPECT images.
*p < 0.01; numbers indicate correlation coefficient (p-value).
Clinical significance of the functional networks in ASL-MRI and ECD-SPECT
Correlation maps of rCBF or PI with CASI total and short-term memory subdomain CASI scores are shown in Supplementary Figures 2 and 3. The global CASI scores and short-term memory scores were positively correlated with PI in bilateral medial and lateral temporal lobes, PCC, precuneus, and angular gyrus. With regards to rCBF, significant regions were shown in the posterior parietal, inferior temporal, PCC, precuneus, and angular gyrus.
Results of partial correlation between language composite score and PI (Fig. 5A) and rCBF (Fig. 5B) adjusted for age and education were lateralized to the left hemisphere. The language composite scores were correlated to PI in the anterior and superior temporal lobe (Fig. 5A) and the rCBF in the left angular gyrus, PCC and left-mid frontal gyrus (Fig. 5B).
Cerebral vascular risk factors may affect regional rCBF and PI
Simple correlation analysis showed significant relationships between the level of HDL and rCBF in the PCC, even after adjusting for the severity of dementia and age (both p < 0.01) (Table 4). hsCRP was inversely correlated with frontal, lateral temporal, medial temporal and PCC PI (p < 0.01). After adjusting for age and CDR sum of box, the significant association remained in the lateral temporal and PCC regions (Table 4).
Table 4.
Regional of interests | HDL and rCBF | hsCRP and PI | ||
---|---|---|---|---|
Simple correlation | Adjusted correlation# | Simple correlation | Adjusted correlation# | |
Frontal | −0.03(0.817) | −0.25(0.313) | −0.34(0.002)* | −0.29(0.011) |
Lateral temporal | −0.17(0.129) | −0.14(0.193) | −0.37(0.001)* | −0.29(0.006)* |
Medial temporal | −0.08(0.481) | −0.54(0.625) | −0.30(0.007)* | −0.24(0.031) |
Occipital | 0.19(0.101) | 0.16(0.122) | −0.15(0.199) | −0.08(0.470) |
Parietal | 0.10(0.389) | 0.08(0.443) | −0.21(0.06) | −0.15(0.187) |
Angular | 0.03(0.777) | 0.02(0.884) | −0.26(0.019) | −0.19(0.078) |
Posterior Cingulate Cortex | 0.30(0.007)* | 0.28(0.006)* | −0.36(0.001)* | −0.28(0.007)* |
Precuneus | 0.15(0.187) | 0.13(0.181) | −0.14(0.231) | −0.06(0.600) |
Abbreviations: HDL, high-density lipoprotein; hsCRP, high sensitive C-reactive protein; rCBF, relative cerebral blood flow; PI, perfusion index.
#Adjusted for age and clinical dementia rating sum of box.
*p < 0.01; numbers indicate correlation coefficient (p-value).
Discussion
Major findings
Based on the multiparametric imaging modalities, this study tested the inter- relationships between perfusion status and GM atrophy. There were four major findings. First, both ASL-MRI and ECD-SPECT showed low perfusion in the angular gyrus and PCC. Regions showing dissociation in two perfusion modalities were maily localized in the lateral temporal, medial temporal and occipital. The dissociation patterns may reflect the differences of tracer properties in physiological dynamics. Second, we observed significant linear relationships between the MTC GM volume and rCBF of PCC and angular gyrus. With previous pathological40–42 and longitudinal studies43, we purposed possible mechanisms to support the link between MTC atrophy, watershed hypoperfusion and watershed atrophy. Third, regional cortical perfusion in the superior and anterior temporal lobe areas in PI image and left MCA watershed in rCBF image is associated with language scores. Fourth, our results suggest that an elevated level of hsCRP and a decreased level of HDL are serum risk biomarkers for cerebral hypoperfusion. Although both ASL-MRI and ECD-SPECT provide information on cerebral perfusion, the differences in regional perfusion patterns and vascular risk factors highlight the different mechanisms and clinical perspectives of these two types of perfusion scan.
Dissociations in two perfusion modalities
Our study is the first to compare ECD-SPECT and ASL-MRI perfusion pattern in AD. We found dissociations in regions showing lower CBF (posterior parietal and inferior temporal lobe) and PI (medial and superior temporal lobe). The regions showing dissociations in two perfusion modalities may implicate differences in tracer uptake mechanisms.
Signals of ECD-SPECT often reflect the microvasculature status as the retain of Tc99m-ECD in the brain parenchyma are rapid and the clearance is slow13. Based on the tracer properties, the half-life of ECD in the brain parenchyma is long enough to allow the tracer to saturate within the microvasculature environment so the acquisition time can be at set 1/2 hour or later. In physiological conditions, regional cortical activation depends on the demand of glucose and the blood flow13. Therefore, lower PI in our AD patients may reflect decreases of metabolic demands due to GM atrophy and disturbance of the microvasculature circulation. The topographic relationships between MTC GM atrophy and local or distant region PI were observed in our study that may support the aforementioned mechanisms.
In contrast, ASL-based perfusion measurement involves a race between the decay of the spins and the delivery of labeled blood to the tissue30. Previous study44 showed that flow velocity related to macro-circulation and impairment of vascular autoregulation could influence CBF patterns. Mutsaerts et al.39 also suggested that CBF without vessel suppression reflected macro- and micro-vascular compartment. As the accentuation of signals in ASL-MRI provide additional information of the macro-circulation45, we purposed that areas with rCBF/PI dissociations (lower rCBF but without lower PI) were related to macro-circulation insufficiencies. The posterior parietal and inferior temporal lobe showing low rCBF were located in the distal PCA territory and middle frontal cortex was located in the MCA-ACA watersheds. These findings were consistent with our theory.
Cerebral hypoperfusion related to global or distant region atrophy
Mismatch of cerebral hypoperfusion and GM atrophy in AD has been reported in studies using SPECT43, PET46 and perfusion MRI47,48. The most consistent finding across several ASL perfusion studies of AD is decreased CBF in PCC, precuneus and posterior temporoparietal cortex9,49. As the disease progress43, the hypoperfusion can extend to parieto-occipital cortex, inferior temporal9 and middle frontal cortex35. In contrast, medial temporal lobe atrophy is more an early imaging biomarker in AD and more profound than the anterior and superior temporal lobe43. The mismatch of topography in ASL image and atrophy were similarly observed before47. As the study population and enrollment criteria may not be the same across different studies, the small inconsistency may reflect differences of demographic data and disease severities. One ASL perfusion study12 suggested that the hypoperfusion pattern may be served as a diaschisis indicator of MTC damage. Another perfusion study48 suggested the phenomenon be related to functional disconnection. Current study directly reported significant correlations between MTC volume and rCBF at angular gyrus, PCC and precuneus so the structural-functional inter-relationships of the mismatches were validated. However, we speculate that these areas are located in the watersheds50, hence they are vulnerable to the flow insufficiency.
Cerebral hypoperfusion related to vascular insuffiencies by disease pathology
By transcranial Doppler, smaller hippocampal volumes can lead to a decrease of CBF velocity51. As β-amyloid deposition in MTC areas may lead to volume atrophy and reduce the demand of CBF from PCA, PCA watershed areas are the most vulnerable regions if small vessel disease or impairment of autoregulation coexisted. Because ASL perfusion MRI was sensitive to the changes of macro-circulation, as disease progress the decrease in distal PCA blood flow would affect the rCBF to the posterior parietal and inferior temporal lobes.
Comparing the topographies of reduced PI and GM atrophy in our AD group, the spatial extent overlapped considerably in the posterior parietal association cortex, and PCC which is in agreement with previous reports43,52. An interesting finding was that MTC showed a small decrease in PI with or without PVE. Based on the physiological nature of SPECT, the PI results may have been confounded by volume atrophy and neuronal integrity36. However in one investigation, a mismatch of hypoperfusion and atrophy was found in very early stage AD43. Depending on the status of the compensatory mechanism, perfusion47 or metabolic rate53 in AD may initially increase and then subsequently decrease. Increased, nearly normal and reduced PI values have been reported in the MTC areas in patients with mild cognitive impairment and AD47,54. Although we enrolled patients with early-stage AD (CDR scores of 0.5 or 1), most of the patients may have initiated decompensatory processes in view of the decreased PI.
Abnormal perfusion related to local atrophy
In normal health brain, regional perfusion is associated with the activity of neurons. Activated neurons have increased glucose consumption, but have only a limited ability to store glucose55. Therefore, increased cerebral blood flow is needed to deliver the glucose required for increased metabolic needs so CBF is coupled to neuronal activity55. However, in pathologic brain, the causal effect between hypoperfusion and brain atrophy were more complicated. A few studies focus on the relation between global CBF and total brain volume. One ASL-MRI study suggests adverse effects of reduced cerebral perfusion on brain structure in older adults with cardiovascular disease56. Another ASL-MRI study57 concluded that lower CBF reflects disease burden of both neurodegeneration and small vessel disease in AD. In the longitudinal study42, one study suggested brain atrophy causes CBF to decrease over time, and only in persons aged >65 years of age with the impairment of autoregulatory, hypoperfusion may have the adverse effect on brain volume. In the current study, we delineated the relationships between perfusion in angular gyrus and precuneus and their corresponding cortical volume which is independent to MTC volume and age.
Confounding factors for watersheds perfusion changes
Although the cross-sectional design of the current study precludes interpretation of directionality, such findings raise the possibility that cerebral hypoperfusion is a significant contributing factor to adverse brain changes. In patients with40 and without AD41, pathological studies have provided evidence linking cerebral hypoperfusion and cortical watershed microinfarcts. Neurovascular units include perivascular neurons, astrocytes and vascular endothelial cells that control cerebral autoregulation to ensure sufficient CBF for daily metabolic needs58. Individuals with cerebral vascular risk factors often have dysregulated autoregulation and their neurons may be vulnerable even in physiological conditions such as changing posture59. Cerebral hypoperfusion in AD can be complex, and factors including aging, cerebral vascular risk factors3, β-amyloid deposition, endothelial dysfunction and autoregulation deficits60 may interact with each other to differing degrees to create a critically attained threshold that triggers microcirculatory disturbances, neuronal damage and atrophy4. As the angular gyrus and precuneus are located in the medial or lateral part of the major vessels watersheds50, their neurons may be vulnerable to slight macro-circulation change with impairment of autoregulation.
Effects of cholinesterase inhibitors on perfusion patterns
In our AD patients, they were treated with cholinesterase inhibitors. Claassen et al.61 proposed Cholinergic–Vascular Hypothesis from experiments, preclinical and clinical evidence. They suggested the effect of cholinesterase inhibitors on CBF is not only from increased metabolism but also direct vasodilatation. In clinical practice, this group of medication also showed the benefit to patients with vascular dementia62. In current study, since cholinesterase inhibitors would diminish the significance of hypoperfusion in AD, we suggest more severe hypoperfusion would be found in AD without treatment. Besides, ameliorate circulation through cholinesterase inhibitors and then improve the clinical symptoms seems to imply the importance of cerebral perfusion in AD. However, with the disease progression, β amyloid resulted in total brain toxicity and finally can’t compensate from increase blood flow.
ASL-MRI as a putative neuronal injury biomarker
We performed correlation analysis between different profiles of cognitive scores and PI or rCBF. Of note, the rCBF signals in the angular gyrus, PCC and middle frontal gyrus reflected predominantly left-hemisphere language composite scores, and these regions are localized in the left MCA watershed territory50. The topography correlated with cognitive scores in ASL-MRI may reflect the putative role of ASL-MRI as a neuronal injury biomarker in patients with AD without major vascular stenosis. The correlation pattern was different from the ECD-SPECT analysis in anterior and superior temporal lobes. The relationships between language networks may be inconsistent due to the different methodologies, however the networks emphasize the importance of the temporal, inferior parietal and posterior frontal lobes.
Low HDL and elevated hsCRP may predict intracerebral hypoperfusion
HDL and hsCRP were both important biomarkers for predicting cerebral perfusion status in this study. The link between cholesterol and atherosclerosis has been well established from epidemiologic and statin therapy studies, while a reduced HDL level is a known risk biomarker for cardiovascular disease63, and it has also been correlated with cognitive function64 and GM volume65. In our ASL-MRI study, the modulation of HDL and cerebral perfusion were identified in the PCC area.
hsCRP is an important biomarker for vascular insufficiency66 that reflects non-specific inflammatory processes. The Bogalusa Heart Study67 reported that hsCRP is an independent predictor for carotid artery intima-media thickness, and the Rotterdam Study68 suggested that hsCRP is a mediator of cerebral small-vessel disease. However, our study is the first to identify an association between hsCRP level and reduced cerebral perfusion. Although indirect, amyloid toxicity may reflect a chronic low-grade inflammatory state that is related to the elevated hsCRP and lower PI shown in ECD-SPECT. It is worth noting that the significance of the correlation between hsCRP and PI decreased after adjusting for the severity of dementia and age. As both factors reflect general measurements of GM atrophy, these findings again reflect the confounding effect of brain volume in ECD-SPECT signals.
Hypoperfusion-Atrophy hypothesis in AD
Figure 6 concluded our hypothesis about the relationship between hypoperfusion and atrophy in AD. In early stage of AD, amyloid deposited in MTC and vessels resulted in neuronal and vascular toxicity. Decreased demand due to atrophy and endothelial dysfunction lead to watershed areas hypoperfusion. Watershed hypoperfusion might influence neuronal function thus causing clinical symptoms. In more aggressive stage of AD, amyloid and tau spread extent which exacerbates the neuronal damage and makes clinical symptoms rapid deterioration. In addition to amyloid related vascular toxicity, other cerebrovascular risk factors including higher hsCRP and lower HDL also caused disturbances of macro- or microvasculature circulation.
Limitations
There are several limitations to this study. First, the sample size in our study was small so our results may not represent all AD patients. Nonetheless, the pattern of cerebral hypoperfuson in this study is similar to previous reports in both SPECT and ASL-MRI studies. Second, the mechanisms between CBF and cortical atrophy are complex and the cross-sectional study design was not able to evaluate the top-down relationships. Further longitudinal follow-ups and experiment studies are needed to validate our observations. Third, the discussion of β-amyloid-related endothelial injury was based on the amyloid toxicity theory. Further analysis incorporating amyloid images may help to delineate the threshold levels as confounded by amyloid load. Lastly, although ASL images were carefully checked and we already excluded those with moderate to severe artery stenosis, mild degrees of labeling insufficiency could still happen. CBF without crushing could retain the signal-to-noise ratio30 and provide more information about macro-vascular circulation39. However, to understand the patterns in patients with vessel stenosis or advanced staging, the consideration of performing multiple post-label delay time and vascular crushing gradients will be necessary to reduce labeling insufficiency and remove the noise in large artery for a more accurate microvasculature CBF value.
Conclusion
In conclusion, this multi-parametric neuroimaging analysis of AD explored the hypoperfusion patterns and delineated the importance of watershed territories. Features of ASL-MRI and ECD-SPECT provided complementary information to structural images. The ASL-MRI patterns reflected macro- and microvasculature circulatory and the ECD-SPECT patterns reflected microvasculature perfusion and tissue compartment. We hypothesize the effect of MTC atrophy on remote hypoperfusion in PCA watershed is through the decrease of PCA flow and impairment of cerebral autoregulation. And then watersheds hypoperfusion may be associated with regional atrophy. However, this hypothesis need further longitudinal and experiment study to prove.
Electronic supplementary material
Acknowledgements
The authors wish to thank the patients and their caregivers for their time and commitment to this research. This work was supported by Chang Gung Memorial Hospital [grant numbers CMRPG8E1011, CMRPG8E0541 and CMRPG8C0571] and the National Science Council [grant number 104-2314-B-182A-026-MY2] to CWH, CCC and CCL for MRI acquisition, SPECT analysis and clinical data collection and analysis.
Author Contributions
Chi-Wei Huang participated in the design of the study, drafted the manuscript and performed the statistical analysis. Shih-Wei Hsu, Chun-Chung Lui and Chen-Chang Lee carried out the MRI acquisition, data analysis, and interpretation. Shu-Hua Huang and Yung-Cheng Huang carried out the ECD-SPECT acquisition, data analysis, and interpretation. Ya-Ting Chang, Wen-Neng Chang and Na-Ching Chen participated in the clinical evaluation of patients and helped draft the manuscript. Chiung-Chih Chang helped draft the work and revise it critically for important intellectual content. All authors read and approved the final manuscript.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Electronic supplementary material
Supplementary information accompanies this paper at 10.1038/s41598-018-19387-x.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:4703–4707. doi: 10.1073/pnas.052587399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368:387–403. doi: 10.1016/S0140-6736(06)69113-7. [DOI] [PubMed] [Google Scholar]
- 3.Breteler MM. Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol. Aging. 2000;21:153–160. doi: 10.1016/S0197-4580(99)00110-4. [DOI] [PubMed] [Google Scholar]
- 4.de la Torre JC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis. Neurobiology of aging. 2000;21:331–342. doi: 10.1016/S0197-4580(00)00111-1. [DOI] [PubMed] [Google Scholar]
- 5.Detre JA, Rao H, Wang DJ, Chen YF, Wang Z. Applications of arterial spin labeled MRI in the brain. Journal of magnetic resonance imaging: JMRI. 2012;35:1026–1037. doi: 10.1002/jmri.23581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Huang CW, et al. Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer’s dementia. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2013;20:1191–1197. doi: 10.1111/ene.12159. [DOI] [PubMed] [Google Scholar]
- 7.Xu G, et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer’s disease. NMR in biomedicine. 2010;23:286–293. doi: 10.1002/nbm.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Okell TW, Chappell MA, Kelly ME, Jezzard P. Cerebral blood flow quantification using vessel-encoded arterial spin labeling. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2013;33:1716–1724. doi: 10.1038/jcbfm.2013.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer’s disease. Journal of Alzheimer’s disease: JAD. 2010;20:871–880. doi: 10.3233/JAD-2010-091699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Andrews-Hanna JR, Reidler JS, Sepulcre J, Poulin R, Buckner RL. Functional-anatomic fractionation of the brain’s default network. Neuron. 2010;65:550–562. doi: 10.1016/j.neuron.2010.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:4637–4642. doi: 10.1073/pnas.0308627101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Holman BL, Tumeh SS. Single-photon emission computed tomography (SPECT). Applications and potential. JAMA: the journal of the American Medical Association. 1990;263:561–564. doi: 10.1001/jama.1990.03440040100036. [DOI] [PubMed] [Google Scholar]
- 13.Catafau AM. Brain SPECT in clinical practice. Part I: perfusion. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 2001;42:259–271. [PubMed] [Google Scholar]
- 14.Dubois B, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet neurology. 2014;13:614–629. doi: 10.1016/S1474-4422(14)70090-0. [DOI] [PubMed] [Google Scholar]
- 15.Yoshiura T, et al. MR relative cerebral blood flow mapping of Alzheimer disease: correlation with Tc-99m HMPAO SPECT. Acad Radiol. 2002;9:1383–1387. doi: 10.1016/S1076-6332(03)80665-7. [DOI] [PubMed] [Google Scholar]
- 16.Olazaran J, et al. Regional correlations between MR imaging perfusion and SPECT in Alzheimer’s disease. Neurologia. 2005;20:240–244. [PubMed] [Google Scholar]
- 17.Jack CR, Jr., et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. The Lancet. Neurology. 2010;9:119–128. doi: 10.1016/S1474-4422(09)70299-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mazza M, Marano G, Traversi G, Bria P, Mazza S. Primary cerebral blood flow deficiency and Alzheimer’s disease: shadows and lights. Journal of Alzheimer’s disease: JAD. 2011;23:375–389. doi: 10.3233/JAD-2010-090700. [DOI] [PubMed] [Google Scholar]
- 19.Huang CW, et al. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer’s dementia. Thromb. Haemost. 2015;114:1230–1240. doi: 10.1160/TH14-11-0938. [DOI] [PubMed] [Google Scholar]
- 20.Dubois B, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 2010;9:1118–1127. doi: 10.1016/S1474-4422(10)70223-4. [DOI] [PubMed] [Google Scholar]
- 21.Chang CC, et al. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2009;16:1144–1150. doi: 10.1111/j.1468-1331.2009.02661.x. [DOI] [PubMed] [Google Scholar]
- 22.Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Annals of neurology. 1980;7:486–488. doi: 10.1002/ana.410070516. [DOI] [PubMed] [Google Scholar]
- 23.Su TC, et al. Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke; a journal of cerebral circulation. 2001;32:2265–2271. [PubMed] [Google Scholar]
- 24.American Diabetes, A Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64–71. doi: 10.2337/dc12-s064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Armstrong C, Joint National, C JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014;90:503–504. [PubMed] [Google Scholar]
- 26.Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
- 27.Teng, E. L. et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. International psychogeriatrics/IPA6, 45–58, discussion 62 (1994). [DOI] [PubMed]
- 28.Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2008;60:1488–1497. doi: 10.1002/mrm.21790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sigurdsson S, et al. Feasibility of Using Pseudo-Continuous Arterial Spin Labeling Perfusion in a Geriatric Population at 1.5 Tesla. PloS one. 2015;10:e0144743. doi: 10.1371/journal.pone.0144743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Alsop DC, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2015;73:102–116. doi: 10.1002/mrm.25197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Good CD, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage. 2001;14:21–36. doi: 10.1006/nimg.2001.0786. [DOI] [PubMed] [Google Scholar]
- 32.Leenders KL, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain: a journal of neurology. 1990;113(Pt 1):27–47. doi: 10.1093/brain/113.1.27. [DOI] [PubMed] [Google Scholar]
- 33.Wang Z, et al. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging. 2008;26:261–269. doi: 10.1016/j.mri.2007.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Aslan S, Lu H. On the sensitivity of ASL MRI in detecting regional differences in cerebral blood flow. Magn Reson Imaging. 2010;28:928–935. doi: 10.1016/j.mri.2010.03.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chen Y, et al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology. 2011;77:1977–1985. doi: 10.1212/WNL.0b013e31823a0ef7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Matsuda H, et al. Correction for partial-volume effects on brain perfusion SPECT in healthy men. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 2003;44:1243–1252. [PubMed] [Google Scholar]
- 37.Pickut BA, et al. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry research. 1999;90:103–112. doi: 10.1016/S0925-4927(99)00004-9. [DOI] [PubMed] [Google Scholar]
- 38.Tzourio-Mazoyer N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002;15:273–289. doi: 10.1006/nimg.2001.0978. [DOI] [PubMed] [Google Scholar]
- 39.Mutsaerts HJ, et al. Cerebral Perfusion Measurements in Elderly with Hypertension Using Arterial Spin Labeling. PloS one. 2015;10:e0133717. doi: 10.1371/journal.pone.0133717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Suter OC, et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke; a journal of cerebral circulation. 2002;33:1986–1992. doi: 10.1161/01.STR.0000024523.82311.77. [DOI] [PubMed] [Google Scholar]
- 41.Raman MR, et al. Antemortem MRI findings associated with microinfarcts at autopsy. Neurology. 2014;82:1951–1958. doi: 10.1212/WNL.0000000000000471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zonneveld HI, et al. The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2015;35:1882–1887. doi: 10.1038/jcbfm.2015.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Matsuda H, et al. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer’s disease. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 2002;43:304–311. [PubMed] [Google Scholar]
- 44.Sorond FA, Hollenberg NK, Panych LP, Fisher ND. Brain blood flow and velocity: correlations between magnetic resonance imaging and transcranial Doppler sonography. J Ultrasound Med. 2010;29:1017–1022. doi: 10.7863/jum.2010.29.7.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Jann K, et al. Implication of cerebral circulation time in intracranial stenosis measured by digital subtraction angiography on cerebral blood flow estimation measured by arterial spin labeling. Diagn Interv Radiol. 2016;22:481–488. doi: 10.5152/dir.2016.15204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Chetelat G, et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer’s disease. Brain: a journal of neurology. 2008;131:60–71. doi: 10.1093/brain/awm288. [DOI] [PubMed] [Google Scholar]
- 47.Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer’s disease. NeuroImage. 2008;42:1267–1274. doi: 10.1016/j.neuroimage.2008.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Wirth M, et al. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2017;37:814–824. doi: 10.1177/0271678X16641128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Chen W, et al. Advances in perfusion magnetic resonance imaging in Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2011;7:185–196. doi: 10.1016/j.jalz.2010.04.004. [DOI] [PubMed] [Google Scholar]
- 50.Naidich TP, Brightbill TC. Vascular territories and watersheds: a zonal frequency analysis of the gyral and sulcal extent of cerebral infarcts. Part I: the anatomic template. Neuroradiology. 2003;45:536–540. doi: 10.1007/s00234-003-1015-z. [DOI] [PubMed] [Google Scholar]
- 51.Ruitenberg A, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Annals of neurology. 2005;57:789–794. doi: 10.1002/ana.20493. [DOI] [PubMed] [Google Scholar]
- 52.Kogure D, et al. Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT. Journal of Nuclear Medicine. 2000;41:1155–1162. [PubMed] [Google Scholar]
- 53.Scarmeas N, et al. Covariance PET patterns in early Alzheimer’s disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. NeuroImage. 2004;23:35–45. doi: 10.1016/j.neuroimage.2004.04.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Ohnishi T, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. Journal of Nuclear Medicine. 1995;36:1163–1169. [PubMed] [Google Scholar]
- 55.Norfray JF, Provenzale JM. Alzheimer’s disease: neuropathologic findings and recent advances in imaging. AJR Am J Roentgenol. 2004;182:3–13. doi: 10.2214/ajr.182.1.1820003. [DOI] [PubMed] [Google Scholar]
- 56.Alosco ML, et al. The adverse effects of reduced cerebral perfusion on cognition and brain structure in older adults with cardiovascular disease. Brain and behavior. 2013;3:626–636. doi: 10.1002/brb3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Benedictus MR, et al. Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer’s disease. Neurobiology of aging. 2014;35:2665–2670. doi: 10.1016/j.neurobiolaging.2014.06.001. [DOI] [PubMed] [Google Scholar]
- 58.del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2003;23:879–894. doi: 10.1097/01.WCB.0000078322.96027.78. [DOI] [PubMed] [Google Scholar]
- 59.Fraser KS, et al. Cerebral hypoperfusion is exaggerated with an upright posture in heart failure: impact of depressed cardiac output. JACC Heart Fail. 2015;3:168–175. doi: 10.1016/j.jchf.2014.07.017. [DOI] [PubMed] [Google Scholar]
- 60.Roy S, Rauk A. Alzheimer’s disease and the ‘ABSENT’ hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Med Hypotheses. 2005;65:123–137. doi: 10.1016/j.mehy.2004.08.031. [DOI] [PubMed] [Google Scholar]
- 61.Claassen JA, Jansen RW. Cholinergically mediated augmentation of cerebral perfusion in Alzheimer’s disease and related cognitive disorders: the cholinergic-vascular hypothesis. J Gerontol A Biol Sci Med Sci. 2006;61:267–271. doi: 10.1093/gerona/61.3.267. [DOI] [PubMed] [Google Scholar]
- 62.Malouf, R. & Birks, J. Donepezil for vascular cognitive impairment. The Cochrane database of systematic reviews, CD004395, 10.1002/14651858.CD004395.pub2 (2004). [DOI] [PubMed]
- 63.Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ. 1994;309:11–15. doi: 10.1136/bmj.309.6946.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Atzmon G, et al. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci. 2002;57:M712–715. doi: 10.1093/gerona/57.11.M712. [DOI] [PubMed] [Google Scholar]
- 65.Ward, M. A. et al. Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci2, 10.3389/fnagi.2010.00029 (2010). [DOI] [PMC free article] [PubMed]
- 66.Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J. 2004;148:S19–26. doi: 10.1016/j.ahj.2004.04.028. [DOI] [PubMed] [Google Scholar]
- 67.Toprak A, et al. C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study) BMC Cardiovasc Disord. 2011;11:78. doi: 10.1186/1471-2261-11-78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.van Dijk EJ, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation. 2005;112:900–905. doi: 10.1161/CIRCULATIONAHA.104.506337. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.